Loeb & Loeb vice chair and co-chair of the firm's Capital Markets and Corporate Practice Mitch Nussbaum speaks on the rise of biotechnology special purpose acquisition companies (SPACs) and their correlation with blank check initial public offerings.
Click here to read the full article on the Law360 website.
-
副主席兼纽约办公室管理合伙人；资本市场及公司业务部联席主席；亚洲业务部主席”; 纽约，北京